Management Accounting
Resume:
STEPHEN TULIPANO, CPA
Stoneham, MA 02180
*******.********@*****.***
FINANCE LEADERSHIP FOR THE ENTERPRISE
Highly experienced and accomplished Finance and Accounting leader with a
record of achievement managing the finances of companies in Pharma,
BioPharma, and Technology with annual revenues over $13 billion and market
capitalization as large as $14 billion. A Strategic Partner and Trusted
Advisor to CEO's and the Board of Directors adept in stewarding budgets and
P&L's as large as $50 million. A problem-solver who thinks strategically
and acts tactically.
Well versed in balance sheet, cash management, risk management, and
Sarbanes Oxley compliance as well as treasury and tax matters including
planning and compliance, contract negotiations, financial regulatory
matters, long range plans, lease negotiations, human resource, payroll and
benefits including salary negotiations and compensation planning.
A history of advancement through increasingly responsible leadership roles
including Director of Corporate Accounting, Chief Financial Officer, and
Secretary. Operationally savvy and practiced in the management of key
business functions including Accounting, Finance, Information Technology,
Pharma Supply Chain Management, Facilities Management, and Human Resource
Management. Recognized as a hands-on manager with exceptional team building
skills.
CORE COMPETENCIES
Public Offerings . Joint Ventures . P&L's . Project Management . Strategic
Planning
Team Leadership & Motivation . Budgeting . Financial Analysis . Financial
Statements . M&A . Reporting
PROFESSIONAL EXPERIENCE
Javelin Pharmaceuticals, Inc. (JAV), Cambridge, MA
2006 - 2010
A pharmaceutical development stage company with three products in phase III
development. Javelin was
purchased by Hospira, Inc. in July 2010 for over $170M.
Chief Financial Officer and Secretary
Played a key role in enabling the corporation to sustain operations in the
face of an economic sea change fueled by the worst economic downturn since
the 1930's. Held the financial tiller while positioning the company to
bring a key product to market and to deliver value to shareholders through
its sale to Hospira.
Served as Partner and Trusted Advisor to 2 successive CEO's and the Board
of Directors. Closely managed the efforts of professionals in Accounting,
Finance, Information Technology, Pharma Supply Chain Management, Facilities
Management, and Human Resource Management. Partnered with the CEO and VP of
BD on all business development negotiations. Chaired the Joint Steering
Committee with Therabel on the European licensing of Dyloject.
Stewarded P&L's and budgets as large as $45M. Guided capital raises in
public and private markets. Led and managed all public SEC filings
including interfacing with financial analysts, shareholders, and investment
banks. Controlled General and Administration spending ranging from $4M to
$8M per annum.
. Played a pivotal role in funding ongoing company operations. Spearheaded
the raising of over $76M in public and private capital placements while
taking the lead in managing relations with investment banks, attorneys,
auditors, and over 5,000 investors and potential investors.
. Enabled Javelin to position itself for $55.5M in potential earnings from
the product Dyloject. Partnered with the CEO in out-licensing Dyloject in
Europe while driving $11M in cash for upfront milestone and inventory.
. Avoided a disastrous security market collapse in late 2007. Liquidated
more than $11M in auction rate securities well in advance of the
collapse.
. Provided value for more than 5,000 shareholders. Helped orchestrate the
sale of Javelin to Hospira for more than $170M.
. Ensured timely SOX compliance in a highly regulated industry. Achieved
SOX compliance in only 6 months through accelerated filing. Maintained
compliance for 4 years running with no material weaknesses or significant
deficiencies.
. Listed the Company on the NYSE American Stock Exchange (AMEX).
STEPHEN TULIPANO, CPA PAGE TWO
Biogen Idec, Inc. (BIIB), Cambridge, MA
1998 - 2006
One of the oldest biopharmaceutical companies in the US with over $4B in
revenues and $14B in market capitalization.
Director of Corporate Accounting
Fueled the development of a world-class accounting function with turnover
well below industry standards. Orchestrated the efforts of 21 accountants
supporting external reporting, technical accounting, research and
development, manufacturing, sales, general and administrative and the
information technology functions. Provided high level direction in
budgeting, forecasting, and latest estimate and P&L reporting as well as
all financial reporting, worldwide closing and global consolidations.
Served as senior liaison to the SEC while leading the development of all
accounting policies and procedures as well as the adoption around the
globe.
. Provided the CEO and CFO with an early view of anticipated revenue and
earnings while enabling a significant reduction in closing cycle time.
Personally developed and managed the latest estimate process worldwide.
. Enabled Biogen to achieve recognized revenues of $700M. Partnered with
the business development group to develop an innovative commercial
partnership model for Tysabri.
. Led the development of the Biogen Finance Mentoring Program which played
a pivotal role in establishing a corporate wide mentoring program
delivered by Human Resources.
Digital Equipment Corporation (DEC), Maynard, MA
1996 - 1998
A leading computer manufacturer acquired by Compaq in 1998. DEC's market
capitalization at the time of the acquisition was approximately $10B.
External Reporting Manager
Drove the preparation of public financial reports, including 10Q's, 10K's,
and earnings reports while providing accounting insight and oversight
across more than 5 business units. Advised BU management on all accounting
matters, new accounting regulations, and accounting regulation
interpretation. Ensured compliance while enabling management to better
understand the impact of regulations on their respective business units.
. Earned management accolades as recipient of the 1998 Digital Equipment
Corporation CFO Award. Gained recognition of more than $160M for pension
and retiree healthcare modifications over a 2- year period.
. Provided critical accounting contributions to a $150M spinoff of the
company's Learning Services business unit which later became known as the
Global Knowledge Network.
. Delivered accounting and business consulting buyers during a 6-month
transition period.
. Assisted in the merger of Compaq and DEC and worked for Compaq for 8
months to ensure a methodical transition.
EARLY CAREER
Groundwater Technology, Inc. Norwood, MA Accounting Supervisor
1993 - 1996
Collaborative Research, Inc. Waltham, MA Sr. Accountant
1991 - 1993
Laventhol & Horwath, LLP Boston, MA Audit Senior
1990
Tofias, Fleishman, Shapiro Cambridge, MA Audit Senior
1987 - 1989
EDUCATION
MBA, Concentration in Finance, Sawyer School of Management; Suffolk
University, Boston, MA
BS, Business Administration and Accounting, Salem State College, Salem, MA
AFFILIATIONS
Member of the American Institute of Certified Public Accountants
Member of the Massachusetts Society of Certified Public Accountants, Past
board member of the Business and Industry subcommittee of the Massachusetts
Society of Certified Public Accountants
NATIONAL SERVICE
Massachusetts Army National Guard - (Hon), Troop A 1-26th Armored Cavalry
Squadron
United States Navy - (Hon), USS San Diego (AFS-6), USS Damato (DD-871),
SIMA Little Creek
Contact this candidate